Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Blood plasma solute removal via convection is not a molecule, receptor, protein, or drug target but rather a physical transport process used in therapies such as hemofiltration, hemofiltration-based continuous renal replacement therapy (CRRT), and hemodiafiltration. It refers to the bulk movement of blood plasma water across a semi-permeable membrane under a pressure gradient, carrying dissolved solutes (including small and middle-molecular-weight toxins) by solvent drag[2][3][5][6]. This process is utilized in medical devices such as artificial kidneys, dialysis filters, and hemofilters, and is essential in the management of acute kidney injury or kidney failure where natural filtration is impaired[6]. The effectiveness depends on membrane permeability, transmembrane pressure, and molecular size (with larger molecules such as middle-weight proteins being more efficiently cleared by convection compared to diffusion)[1][2][3][4][5][6]. "Blood plasma solute removal via convection" is not a valid therapeutic target in the sense of being a receptor, enzyme, or other discrete molecular entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Blood plasma solute removal via convection.